Tables and Figures: Modelling the Incidence and Prevalence of Hepatitis C Infection and its Sequelae in Canada, 2007

Tables and Figures

• Table 1a: Modelled prevalence and incidence of HCV infection and HCV/HIV co-infection by exposure category and sex among all persons, Canada 2007
• Table 1b: Modelled prevalence and incidence of HCV infection and HCV/HIV co-infection by exposure category and sex among persons born in Canada, 2007
• Table 1c: Modelled prevalence and incidence of HCV infection and HCV/HIV co-infection by exposure category and sex among persons born outside Canada, 2007
• Table 2a: Modelled HCV prevalence by age group and sex among all persons, Canada, 2007
• Table 2b: Modelled HCV prevalence by age group and sex among persons born in Canada, 2007
• Table 2c: Modelled HCV prevalence by age group and sex among persons born outside Canada, 2007
• Table 3a: Modelled HCV incidence by age group and sex among all persons, Canada 2007
• Table 3b: Modelled HCV incidence by age group and sex among persons born in Canada, 2007
• Table 3c: Modelled HCV incidence by age group and sex among persons born outside Canada, 2007
• Table 4a: Modelled HCV prevalence by province/territory and exposure category, Canada, 2007
• Table 4b: Modelled HCV prevalence (number and proportion) by province/territory and by exposure category, Canada, 2007
• Table 5: Modelled HCV infection in the Aboriginal population, Canada, 2007
• Table 6a: Modelled HCV infection among incarcerated persons, Canada 2005
• Table 6b: Modelled HCV prevalence among incarcerated persons by type of institution and region, Canada, 2005
• Table 6c: Modelled HCV prevalence among incarcerated persons by region and IDU vs non-IDU, Canada, 2005
• Table 7a: Modelled incidence of HCV infection and sequelae by five-year interval, Canada, 1967-2027
• Table 7b: Modelled prevalence of HCV infection and sequelae (not exclusive) by five-year interval, Canada, 1967-2027
• Table 7c: Modelled prevalence of HCV infection and sequelae (exclusive) by five-year interval, Canada, 1967-2027
• Table 8a: Number of HCV cases reported to the Public Health Agency of Canada by year of report and province/territory, unadjusted, Canada 1991-2007
• Table 8b: Number of HCV cases reported to the Public Health Agency of Canada by year of report and province/territory, adjusted, Canada, 1991-2007
• Table 8c: Comparison of modelled with reported HCV cases surviving to 2007 by province/territory, Canada 2007

 

• Figure 1: Markov model of transition through stages of HCV infection
• Figure 2: Modelled incidence of HCV sequelae by five-year interval, Canada 1967-2027
• Figure 3: Modelled prevalence (not exclusive) of HCV sequelae by five-year interval, Canada 1967-2027
• Figure 4: Number of reported HCV diagnoses by year, adjusted, Canada, 1991-2007
• Figure 5: Prevalence (number and rate) of surviving reported HCV cases by province/territory, Canada, December 2007